Found: 12
Select item for more details and to access through your institution.
Simulated Medicare Drug Price Negotiation Under the Inflation Reduction Act of 2022.
- Published in:
- JAMA Health Forum, 2023, v. 4, n. 1, p. e225218, doi. 10.1001/jamahealthforum.2022.5218
- By:
- Publication type:
- Article
What Should US Policymakers Learn From International Drug Pricing Transparency Strategies?
- Published in:
- AMA Journal of Ethics, 2022, v. 24, n. 11, p. 1083, doi. 10.1001/amajethics.2022.1083
- By:
- Publication type:
- Article
New international pandemic treaty: potential implications for clinicians worldwide.
- Published in:
- 2022
- By:
- Publication type:
- editorial
A Shot of Faith—Analyzing Vaccine Hesitancy in Certain Religious Communities in the United States.
- Published in:
- American Journal of Health Promotion, 2022, v. 36, n. 5, p. 765, doi. 10.1177/08901171211069547
- By:
- Publication type:
- Article
Promoting Competition in Drug Pricing: A Review of Recent Congressional Legislation.
- Published in:
- Journal of Law, Medicine & Ethics, 2021, v. 49, n. 4, p. 683, doi. 10.1017/jme.2021.93
- By:
- Publication type:
- Article
HEALTHY COOPERATION IN A MULTIPOLAR WORLD: THE FATE OF THE NEW INTERNATIONAL PANDEMIC TREATY.
- Published in:
- Harvard International Review, 2021, v. 42, n. 4, p. 21
- By:
- Publication type:
- Article
A SILENT KILLER: THE RISE OF THE ONLINE PRESCRIPTION DRUGS ILLICIT MARKET.
- Published in:
- Harvard International Review, 2021, v. 42, n. 2, p. 51
- By:
- Publication type:
- Article
Broad Patent Claims Come Before the Supreme Court in Amgen v Sanofi.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 19, p. 1641, doi. 10.1001/jama.2023.5638
- By:
- Publication type:
- Article
Five-Year Sales for Newly Marketed Prescription Drugs With and Without Initial Orphan Drug Act Designation.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 18, p. 1607, doi. 10.1001/jama.2023.3079
- By:
- Publication type:
- Article
Recent Patent Reform Bills and Their Implications for Prescription Drugs.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 329, n. 6, p. 459, doi. 10.1001/jama.2022.24983
- By:
- Publication type:
- Article
A systematic review of economic evaluations of pharmacological treatments for active tuberculosis.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2024.1201512
- By:
- Publication type:
- Article
The prevalence of drug patent term extensions in the United States, 2000–2018.
- Published in:
- Nature Biotechnology, 2023, v. 41, n. 7, p. 903, doi. 10.1038/s41587-023-01847-z
- By:
- Publication type:
- Article